Royal Bank of Canada
NEPH icon

Royal Bank of Canada’s Nephros NEPH Stock Holding History

Royal Bank of Canada’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Buy
747
+9
+1% +$36 ﹤0.01% 6728
2025
Q4 		$4K Buy
738
+736
+36,800% +$3.76K ﹤0.01% 6782
2025
Q3 		$0 Hold
2
– – ﹤0.01% 7370
2025
Q2 		$0 Hold
2
– – ﹤0.01% 7229
2025
Q1 		$0 Hold
2
– – ﹤0.01% 7094
2024
Q4 		$0 Buy
+2
New +$3 ﹤0.01% 7124
2023
Q3 		– Sell
-1
Closed – – 7397
2023
Q2 		$0 Hold
1
– – ﹤0.01% 7522
2023
Q1 		$0 Hold
1
– – ﹤0.01% 7337
2022
Q4 		$0 Buy
+1
New +$1 ﹤0.01% 7544
2021
Q3 		– Sell
-7
Closed – – 7783
2021
Q2 		$0 Sell
7
-20
-74% -$167 ﹤0.01% 7613
2021
Q1 		$0 Buy
+27
New +$213 ﹤0.01% 7599

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Royal Bank of Canada's NEPH Position: Q1 2026 in Review

Royal Bank of Canada increased its Nephros (NEPH) stake by 1.2% in Q1 2026, buying an estimated $36 and bringing the position to 747 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #6728.

Royal Bank of Canada first reported a position in NEPH in Q1 2021 and has held it in 11 quarters since. The position peaked at $4K in Q4 2025. 27 funds tracked by Wall St. Rank hold NEPH as of Q1 2026.

  • Royal Bank of Canada held 747 shares of Nephros worth $2K as of Q1 2026.
  • Royal Bank of Canada bought 9 Nephros shares in Q1 2026, an estimated $36.
  • Nephros made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6728 holding.
  • Royal Bank of Canada first reported a position in Nephros in Q1 2021 and has held it in 11 quarters since.
  • Royal Bank of Canada's Nephros position peaked at $4K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Nephros as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.